Over the past few decades, advances in hematology have illuminated how a delicate balance between stem cell self-renewal and differentiation sustains healthy blood formation. In myelodysplastic ...
CD19-targeted CAR T-cell therapy shows a 65% response rate in Richter transformation, with median progression-free survival of 8 months and overall survival of 14.4 months. Early response and age are ...
A research team led by Professor June M. Kwak from the Department of New Biology at DGIST (President Kunwoo Lee), in collaboration with Professor Jong Kyoung Kim’s team at POSTECH, has uncovered the ...